Figure 4.
Relapse-free and overall survival of 96 patients with gastric cancers according to their MKK4 status. Patients with MKK4 protein expressed in gastric cancer tissues had significantly poorer relapse-free and overall survival rates than those without MKK4. Numbers in parentheses represent the total number of patients per group.